One-Step Drug Screening System Utilizing Electrophysiological Activity in Multiple Brain Organoids

Area of Science:

• Neuroscience
• Stem Cell Biology
• Drug Discovery

Background:

• Human-induced pluripotent stem cell (iPSC)-derived brain organoids offer advanced models for studying the human brain and developing new drugs.
• Disease model organoids, created from patient cells, hold promise for personalized medicine and drug screening.
• A significant challenge in brain organoid research is the lack of a comprehensive system for drug administration and functional efficacy assessment.

Purpose of the Study:

• To introduce a novel, one-step drug screening system for brain organoids.
• To enable the investigation of functional changes induced by various drug doses in multiple brain organoids.
• To facilitate dose-dependent drug screening and personalized medicine applications.

Main Methods:

• Development of a specialized culture chamber with a microfluidic chip for accommodating 10 brain organoids.
• Integration of a three-dimensional microelectrode array (3D MEA) with ten shanks for functional assessment.
• Utilizing electrophysiological signal measurements to analyze neural activity changes.

Main Results:

• Demonstrated real-time analysis of neural activity changes in response to different doses of potassium chloride (KCl).
• Successfully showcased the system's utility in disease-model-based drug screening using SCN2A-epileptic organoids.
• Validated the platform's capability for dose-dependent drug screening across multiple organoids.

Conclusions:

• The developed system provides a comprehensive platform for functional drug screening using brain organoids.
• This technology advances the potential for personalized medicine by enabling tailored drug efficacy assessments.
• The system supports efficient and effective drug screening for neurological diseases and conditions.